The world is not enough
Nairobi, Kenya
Joined September 2016
- Tweets2.7K
- Following120
- Followers411
- Likes5.6K
Mzee retweeted
Behind every cardiovascular statistic is a woman, a story and a life worth protecting.
These patient advocates remind us why women's heart health matters.
From evidence to action. From survival to quality of life.
Progress is measured in lives improved, not conferences convened.
#WomensHeartHealth
@kenyacardiacs
@Apog_Kenya
@mzeengunga
@Starlight_Bo
@WomenAs1
@worldheartfed
Mzee retweeted
Pregnancy is not just nine months. It is a cardiovascular health story that spans a woman’s lifetime.
Dr. Bosire compares a woman’s journey to an F1 race, navigating different challenges through adolescence, pregnancy &menopause. #KCS #APOGKenya #Africanwomenshearthealthsymposium
Mzee retweeted
Understanding #POTS starts with trusted information. CardioSmart’s POTS hub offers patient-friendly information on symptoms, diagnosis, treatment, questions to ask the care team and self-advocacy. Check out the hub here: bit.ly/4y8Bhgb
#CardioSmart #POTSAwarenessDay
Mzee retweeted
Dr. Barasa takes the delegates through #peripartum #cardiomyopathy, a condition that affects the heart around the end of pregnancy or in the months following delivery. Recognising it early and ensuring timely assessment and care are essential
#WomensHeartHealth #KCS #APOGKenya
Mzee retweeted
SCAD calls for careful, individualised management
Dr. Ngunga discusses (SCAD), including recommendations for mild to moderate physical activity & delicate decisions involved in management, including PCI
#KCS #APOGKenya #Africanwomenshearthealthsymposium
Mzee retweeted
During the 2nd panel discussion, Dr. Bosire, highlights the need to strengthen pre-menopausal care, address gaps in evidence on cardiovascular outcomes, &develop policies that make quality care &treatment more accessible &affordable in Kenya.
#WomensHeartHealth #KCS #APOGKenya
Mzee retweeted
Dr. Ngunga points to the need for public awareness of #cardiovascular risks, alongside the work health professionals are doing. Raises concerns about #environmentaltoxins, resources needed to address chronic conditions, & policies required to support #research and innovation.
Mzee retweeted
🫀Finerenone vs spironolactone in heart failure with mildly reduced or preserved ejection fraction: a real-world study. see@ ow.ly/LcYk5100u04
@EJHFEiC @AmrAbdin10 @GiuseppeGalati_ @HanCardiomd @EJHFEiC @JanBiegus @ppponikowski #HFA_ESC @hvanspall @FudimMarat @gcfmd @MarcoMetra @GianluSava
#ESCHeartFailure
Mzee retweeted
💊 Can SGLT2 inhibitors improve outcomes in transthyretin cardiac #Amyloidosis?
A #JACCAdvances meta-analysis of 14 observational studies (n=10,852) found #SGLT2i use was associated with 56% lower all-cause mortality & 38% lower HF hospitalization.
bit.ly/4sjrhPO
Mzee retweeted
African women deserve better cardiovascular outcomes.
Stronger evidence. Earlier diagnosis. Equitable care.
On 24 October, Nairobi hosts the inaugural African Women's Heart Health Symposium.
Beyond awareness. Towards action.
#WomensHeartHealth
@kenyacardiacs
@Apog_Kenya
@WomenAs1
@worldheartfed
@Starlight_Bo
@mzeengunga
To the doctors:
What I See before Anyone Speaks | New England Journal of Medicine nejm.org/doi/full/10.1056/NE…
Mzee retweeted
Women's Heart Health: From Awareness to Action. ❤️
African women remain underrepresented in cardiovascular research, underdiagnosed and undertreated.
On 24 October in Nairobi, we move from evidence to action.
Better science. Equitable care. Healthier generations.
citizen.digital/article/land…
@kenyacardiacs
@Apog_Kenya
@MOH_Kenya
Mzee retweeted
Menopause is not heart disease. But midlife is an important window for cardiovascular prevention.
The priority is not to medicalise menopause, but to recognise evolving risk, investigate symptoms appropriately and intervene early.
Women's heart health requires a life-course approach.
#WorldMenopauseDay
@kenyacardiacs
Mzee retweeted
In 6,558 #ACS pts from MATRIX trial, angiographically-defined #OMI identified pts w/ >1-year mortality—while adding troponin peak values ⬆️ OMI frequency but diluted prognostic effects. NSTE-ACS pts mtg OMI criteria had STEMI-equiv. mortality.
#JACCINT
bit.ly/4jpROZq
Mzee retweeted
Now publ in EHJ: In 3 RCTs (n=704), 2-3-mo Rx w/DOACs (low dose in 2 trials) ↓ device-related thrombosis (DRT) and major bleeding c/w DAPT, with NS Δ in death and stroke/SE. DRT has been associated with thromboembolic events, and the RR of 0.61 for stroke/SE favors DOAC use.
Mzee retweeted
Six 15-min sessions of microbubble cavitation over 18 days increased microvascular density 1.6-fold and femoral flow 1.8-fold, promoting ulcer healing in no-option CLTI. A small trial, but a potential new avenue.
#JACCIMG #cvPAD #cvImaging
bit.ly/4y9skCY
Mzee retweeted
Young woman needs aortic valve replacement + wants pregnancy: choose mechanical or bioprosthetic valve? Swedish data: bioprosthesis → more deliveries (50.5% vs 9.5%) but ↑15-y reintervention (46.5% vs 6.9%). bit.ly/4sfFMnT
#ACCRepOB #JACC @MichaelDismorr
